Buy RXi Pharma Stock | RXII Stock Price & Latest News | Public.com
RXII

RXi Pharma

    We couldn’t load this chart.

    Some stock charts might currently not be supported. To try again, please refresh this page.

    View RXi Pharma (RXII) stock trends here

    About RXII

    SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company. It engages in the development and commercialization of immunotherapeutic for cancer indications. The firm's product pipeline includes galinpepimut-S and nelipepimut-S. The company was founde...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    Stats

    Market Cap$127,46M
    Volume
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$19.38
    1 Year Low$1.61
    Open
    High
    Low

    Buy any stock with any amount of money.

    Download the App
    Download the app